Matches in Nanopublications for { ?s ?p "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP327743.RAisK-XprhBdALO0X3NspGeCQJ0G2Ta-dLvw4MknWc_mE130_provenance.
- NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522313.RAdHLGklAOqdTnEa15UYyw6X-m6ONap9bjy_XrOXt_RJ8130_provenance.
- assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP262843.RARL8qJkbMGLkk8h2ybyxKUXQyShvTCC6NyFca9oJ1t4M130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262843.RARL8qJkbMGLkk8h2ybyxKUXQyShvTCC6NyFca9oJ1t4M130_provenance.
- assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP708586.RAYVizIyHBHuYoGCzs1gIfVSO2uOScu5TXFLGlDTree0g130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708586.RAYVizIyHBHuYoGCzs1gIfVSO2uOScu5TXFLGlDTree0g130_provenance.
- NP829630.RArLl3wHKTVETz8IQrcKrq0Bj5rzihnz508xNXnmfhmiQ130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829630.RArLl3wHKTVETz8IQrcKrq0Bj5rzihnz508xNXnmfhmiQ130_provenance.
- NP907030.RAOZeV6EaeCHqD5lhsTO4iNgQY6VGvfPBSeZ5rc9iuyz0130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907030.RAOZeV6EaeCHqD5lhsTO4iNgQY6VGvfPBSeZ5rc9iuyz0130_provenance.
- NP708583.RANYf9rFIwHDxEi_SAHLehk2ieKoH3xQ9OmZm708zx-PM130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708583.RANYf9rFIwHDxEi_SAHLehk2ieKoH3xQ9OmZm708zx-PM130_provenance.
- NP708585.RAwfRzmpbtr2CFRtKOBUaBMp7JaVxRZnG8MzjUpVHIo2g130_assertion description "[Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77-based mechanism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708585.RAwfRzmpbtr2CFRtKOBUaBMp7JaVxRZnG8MzjUpVHIo2g130_provenance.